1. Pink Sheet
  2. >>Geography

Canadian Firm Scathing On Obstacles To Compulsory Licensing

Biolyse Is Determined To Manufacture J&J’s COVID-19 Vaccine

 
• By Francesca Bruce

Biolyse is seeking a compulsory license for J&J’s COVID-19 vaccine but achieving its goal is proving to be far from easy. The Canadian company argues that its experience illustrates the need for a change in approach to intellectual property rights at a local and global level.

Labirynth
Canada's compulsory licensing system is like a labirynth • Source: Alamy

Bolivia has signed an agreement with the Canadian company Biolyse that allows it to buy low-cost generic versions of Janssen Biotech Inc./Johnson & Johnson’s COVID-19 vaccine. Biolyse is now seeking a compulsory license so that it can go ahead and produce the one-dose shot.

More countries have expressed interest in signing a similar agreement to the one Bolivia has signed with Biolyse

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Canada

More from North America